Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Adipose Derived Stem Cells for IPF
NCT02135380Phase 2Unknown
- Sponsor
- Kasiak Research Pvt Ltd.
- Start
- Aug 2014
- Primary completion
- Aug 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose-derived stromal vascular fraction, autologous adipose derived mesenchymal stem cells in idiopathic pulmonary fibrosis (IPF), sponsored by Kasiak Research Pvt Ltd.. Status: unknown.
02
Drugs
autologous adipose-derived stromal vascular fractionautologous adipose derived mesenchymal stem cells
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT02135380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135380.